PerioTrap is an early stage biopharmaceutical company that aims to eradicate the root cause of periodontitis.
PerioTrap Pharmaceuticals GmbH has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
PerioTrap Pharmaceuticals GmbH's investors include bmp Ventures, Companisto, IBG Beteiligungsgesellschaft Sachsen-Anhalt, i&i Prague, Ferton Holding SA.
PerioTrap Pharmaceuticals GmbH is headquartered in Haale, Germany.
PerioTrap is an early stage biopharmaceutical company that aims to eradicate the root cause of periodontitis.
PerioTrap Pharmaceuticals GmbH is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PerioTrap Pharmaceuticals GmbH — Funding & Investors." VCBacked, January 30, 2025, https://www.vcbacked.co/company/periotrap-pharmaceuticals-gmbh. Accessed October 30, 2026.
VCBacked. (2025). PerioTrap Pharmaceuticals GmbH — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/periotrap-pharmaceuticals-gmbh
{{cite web |title=PerioTrap Pharmaceuticals GmbH — Funding & Investors |url=https://www.vcbacked.co/company/periotrap-pharmaceuticals-gmbh |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated